Catalyst Pharmaceuticals\' Firdapse garners FDA approval for LambertEaton myasthenic syndrome httpswww.firstwordpharma.comnode1607922Â $CPRX

Catalyst Pharmaceuticals' Firdapse garners FDA approval for Lambert-Eaton myasthenic syndrome https://www.firstwordpharma.com/node/1607922  $CPRX

05:31 EST 29 Nov 2018 | FirstWord Pharma

Catalyst Pharmaceuticals' Firdapse garners FDA approval for Lambert-Eaton myasthenic syndrome https://www.firstwordpharma.com/node/1607922  $CPRX

More From BioPortfolio on "Catalyst Pharmaceuticals' Firdapse garners FDA approval for Lambert-Eaton myasthenic syndrome https://www.firstwordpharma.com/node/1607922  $CPRX"